The Illinois plaintiffs, by contrast, argue that Hims products are different enough that describing them as having the same active ingredient misleads consumers
Ro not only has made it very easy for me to get my medication, but theyve also made it easy for me to voice my concerns and symptoms with their medical staff
Were talking about eliminating coverage for a drug that we all acknowledge is highly effective for a condition with high prevalence and enormous downstream costs. MassHealth, the state Medicaid agency, also ended GLP-1 coverage solely for weight loss as of this month, though coverage continues for patients who also have certain other health issues, including diabetes and sleep apnea
Hutchinson treated such cases with the application of caustics and actual cautery
111 In parallel, increased mean diffusivity in the THA/HT and HIP indicates microstructural damage, reinforcing the notion that these regions are coaffected in the disease process